Dr Reddys Laboratories (RDY) Change in Accured Expenses (2018 - 2026)

Dr Reddys Laboratories has reported Change in Accured Expenses for 9 years, with the latest figure at -$111.9 million in Q2 2026.

• On a quarterly basis, Change in Accured Expenses fell 178.64% year-over-year to -$111.9 million in Q2 2026; TTM through Jun 2026 was -$166.8 million, a 68.75% decrease from a year earlier, with the FY2026 full-year figure at $11.0 million, up 112.94% from the prior year.
• Change in Accured Expenses was -$111.9 million for Q2 2026 at Dr Reddys Laboratories, down from -$3.2 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $55.8 million in Q1 2023, with the low at -$111.9 million in Q2 2026.
• Average Change in Accured Expenses over 5 years is -$13.9 million, with a median of -$7.4 million recorded in 2024.
• The largest YoY upside for Change in Accured Expenses was 5863.51% in 2022 against a maximum downside of 965.87% in 2022.
• Over 5 years, Change in Accured Expenses stood at $19.9 million in 2022, then advanced by 7.72% to $21.4 million in 2023, then sank by 153.66% to -$11.5 million in 2024, then soared by 71.98% to -$3.2 million in 2025, then tumbled by 3373.5% to -$111.9 million in 2026.
• The last three Change in Accured Expenses figures came in at -$111.9 million (Q2 2026), -$3.2 million (Q3 2025), and -$40.2 million (Q2 2025), per Business Quant data.